Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 361

1.

Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices.

So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK.

Nutr Cancer. 1996;26(2):167-81.

PMID:
8875554
3.

Inhibition of mammary cancer by citrus flavonoids.

Guthrie N, Carroll KK.

Adv Exp Med Biol. 1998;439:227-36. Review.

PMID:
9781306
4.

Inhibition of oral carcinogenesis by citrus flavonoids.

Miller EG, Peacock JJ, Bourland TC, Taylor SE, Wright JM, Patil BS, Miller EG.

Nutr Cancer. 2008;60(1):69-74. doi: 10.1080/01635580701616163.

PMID:
18444138
5.

Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen.

So FV, Guthrie N, Chambers AF, Carroll KK.

Cancer Lett. 1997 Jan 30;112(2):127-33. Erratum in: Cancer Lett 1997 Dec 9;120(2):245.

PMID:
9066718
6.

Naringin and naringenin are not the primary CYP3A inhibitors in grapefruit juice.

Edwards DJ, Bernier SM.

Life Sci. 1996;59(13):1025-30.

PMID:
8809221
7.

Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin.

Verma AK, Johnson JA, Gould MN, Tanner MA.

Cancer Res. 1988 Oct 15;48(20):5754-8. Erratum in: Cancer Res 1989 Feb 15;49(4):1073.

8.

Black tea and mammary gland carcinogenesis by 7,12-dimethylbenz[a]anthracene in rats fed control or high fat diets.

Rogers AE, Hafer LJ, Iskander YS, Yang S.

Carcinogenesis. 1998 Jul;19(7):1269-73.

PMID:
9683188
9.

Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products.

Ho PC, Saville DJ, Coville PF, Wanwimolruk S.

Pharm Acta Helv. 2000 Apr;74(4):379-85.

PMID:
10812937
10.

Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy.

Hilakivi-Clarke L, Onojafe I, Raygada M, Cho E, Clarke R, Lippman ME.

J Natl Cancer Inst. 1996 Dec 18;88(24):1821-7.

PMID:
8961971
11.

Flavanone absorption after naringin, hesperidin, and citrus administration.

Ameer B, Weintraub RA, Johnson JV, Yost RA, Rouseff RL.

Clin Pharmacol Ther. 1996 Jul;60(1):34-40.

PMID:
8689809
12.
13.

Inhibition of rat mammary tumorigenesis by concord grape juice constituents.

Singletary KW, Stansbury MJ, Giusti M, Van Breemen RB, Wallig M, Rimando A.

J Agric Food Chem. 2003 Dec 3;51(25):7280-6.

PMID:
14640571
14.
15.

Grape juice but not orange or grapefruit juice inhibits platelet activity in dogs and monkeys.

Osman HE, Maalej N, Shanmuganayagam D, Folts JD.

J Nutr. 1998 Dec;128(12):2307-12.

16.
17.

Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice.

Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Rémésy C.

Eur J Clin Nutr. 2003 Feb;57(2):235-42.

PMID:
12571654
18.

Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.

Miniscalco A, Lundahl J, Regårdh CG, Edgar B, Eriksson UG.

J Pharmacol Exp Ther. 1992 Jun;261(3):1195-9.

PMID:
1602384
20.

Esterase inhibition by grapefruit juice flavonoids leading to a new drug interaction.

Li P, Callery PS, Gan LS, Balani SK.

Drug Metab Dispos. 2007 Jul;35(7):1203-8. Epub 2007 Apr 23.

Supplemental Content

Support Center